An Innovative Approach for Tailoring Molecularly Imprinted Polymers for Biosensors—Application to Cancer Antigen 15-3

Daniela dos Santos Oliveira,Andreia Sofia Rodrigues Oliveira,Patrícia Vitorino Mendonça,Jorge Fernando Jordão Coelho,Felismina Teixeira Coelho Moreira,Maria Goreti Ferreira Sales
DOI: https://doi.org/10.3390/bios14050222
2024-05-01
Biosensors
Abstract:This work presents a novel approach for tailoring molecularly imprinted polymers (MIPs) with a preliminary stage of atom transfer radical polymerization (ATRP), for a more precise definition of the imprinted cavity. A well-defined copolymer of acrylamide and N,N′-methylenebisacrylamide (PAAm-co-PMBAm) was synthesized by ATRP and applied to gold electrodes with the template, followed by a crosslinking reaction. The template was removed from the polymer matrix by enzymatic/chemical action. The surface modifications were monitored via electrochemical impedance spectroscopy (EIS), having the MIP polymer as a non-conducting film designed with affinity sites for CA15-3. The resulting biosensor exhibited a linear response to CA15-3 log concentrations from 0.001 to 100 U/mL in PBS or in diluted fetal bovine serum (1000×) in PBS. Compared to the polyacrylamide (PAAm) MIP from conventional free-radical polymerization, the ATRP-based MIP extended the biosensor's dynamic linear range 10-fold, improving low concentration detection, and enhanced the signal reproducibility across units. The biosensor demonstrated good sensitivity and selectivity. Overall, the work described confirmed that the process of radical polymerization to build an MIP material influences the detection capacity for the target substance and the reproducibility among different biosensor units. Extending this approach to other cancer biomarkers, the methodology presented could open doors to a new generation of MIP-based biosensors for point-of-care disease diagnosis.
nanoscience & nanotechnology,instruments & instrumentation,chemistry, analytical
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop a new method for customizing molecularly imprinted polymers (MIPs) for biosensors, especially for the application of cancer antigen 15 - 3 (CA15 - 3). Traditionally, MIPs materials are prepared by radical polymerization. This method is difficult to control during the polymer growth process, resulting in imprecise stereochemical arrangements of imprinted sites, which is particularly important for the detection of protein biomarkers because the intrinsic size and composition of these biomarkers may change. In addition, many cancer biomarkers such as CA15 - 3 exhibit micro - heterogeneity and genetic polymorphism, which further increases the difficulty of detection. To overcome these problems, the authors propose a new method based on atom transfer radical polymerization (ATRP) to synthesize copolymers with specific side groups, which can define the imprinted cavities more precisely. Specifically, a copolymer of acrylamide and N,N' - methylene bisacrylamide (PAAm - co - PMBAm) was synthesized by ATRP, and a cross - linking reaction was carried out after applying the template molecule on the gold electrode. Subsequently, the template molecule was removed by enzymatic/chemical action to form a non - conductive film with CA15 - 3 affinity sites. The main advantages of this method are: 1. **Improved detection sensitivity**: Compared with the traditional radical polymerization MIP, the ATRP - based MIP expands the linear dynamic range of the biosensor by 10 times and improves the low - concentration detection ability. 2. **Enhanced signal reproducibility**: It improves the signal reproducibility between different biosensor units. 3. **Good selectivity and sensitivity**: The developed biosensor shows good sensitivity and selectivity for CA15 - 3. Overall, this work not only shows how to improve the detection ability and reproducibility of MIP materials by improving the polymerization process, but also provides the possibility for developing a new generation of MIP - based biosensors, which can be used for point - of - care (PoC) in disease diagnosis.